| 发明名称 |
USE OF EXENDINS, EXENDIN AGONISTS AND GLP-1 RECEPTOR AGONISTS FOR ALTERING THE CONCENTRATION OF FIBRINOGEN |
| 摘要 |
<p>The present invention relates to altering the concentration of fibrinogen, specifically, for example, by decreasing fibrinogen concentration. The present invention also relates to methods for improving the cardiovascular risk profile of a subject by decreasing fibrinogen concentration.</p> |
| 申请公布号 |
EP2066337(A2) |
申请公布日期 |
2009.06.10 |
| 申请号 |
EP20070836618 |
申请日期 |
2007.08.06 |
| 申请人 |
AMYLIN PHARMACEUTICALS, INC.;ELI LILLY & COMPANY |
发明人 |
KIM, DENNIS;TRAUTMANN, MICHAEL |
| 分类号 |
A61K38/22;A61K38/26;A61P3/10;A61P9/00 |
主分类号 |
A61K38/22 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
